Pritha Bose
-
- Synthesis and biological activity 2
-
- Inflammatory mediators and NSAID effects 2
-
- Cancer, Lipids, and Metabolism 4
-
- Nanoparticle-Based Drug Delivery 3
-
- Cholesterol and Lipid Metabolism 3
-
- Nanoplatforms for cancer theranostics 3
-
- Genomics, phytochemicals, and oxidative stress 2
-
- Nanoparticles: synthesis and applications 2
- Co-authors
- Shakti Prasad PattanayakAntonio LapennaPriyashree SunitaMohd Usman Mohd SiddiqueRajiv K. KarAmiya PriyamPuja KumariSharad Srivastava
- Journals
- Pharmacognosy Magazine (4 papers)Biomedicine & Pharmacotherapy (2 papers)Current Microbiology (1 paper)
- Partner nations
- IndiaUnited KingdomIsrael
In The Last Decade
Pritha Bose
15 papers receiving 343 citations
Peers
Comparison fields: 5 of 63
- Toxicology 15
- Molecular Medicine 20
- Computational Theory and Mathematics 53
- Organic Chemistry 96
- Pharmacology 29
Countries citing papers authored by Pritha Bose
This map shows the geographic impact of Pritha Bose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pritha Bose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pritha Bose more than expected).
Fields of papers citing papers by Pritha Bose
This network shows the impact of papers produced by Pritha Bose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pritha Bose. The network helps show where Pritha Bose may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pritha Bose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 8 | |
| 5 | 2021 | 15 | |
| 6 | 2021 | 2 | |
| 7 | 2021 | 4 | |
| 8 | 2020 | 24 | |
| 9 | 2020 | 48 | |
| 10 | 2020 | 10 | |
| 11 | 2019 | 126 | |
| 12 | 2019 | 7 | |
| 13 | 2019 | 16 | |
| 14 | 2018 | 55 | |
| 15 | 2018 | 26 | |
| 16 | 2018 | 8 |
About Pritha Bose
Pritha Bose is a scholar working on Cancer Research, Biomaterials, Molecular Medicine, Bioengineering and Rehabilitation, having authored 16 papers that have together received 352 indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Cholesterol and Lipid Metabolism (3 papers), Nanoplatforms for cancer theranostics (3 papers), Synthesis and biological activity (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Inflammatory mediators and NSAID effects (2 papers) and Nanoparticles: synthesis and applications (2 papers). The work is most often cited by research in Toxicology (15 citations), Molecular Medicine (20 citations), Computational Theory and Mathematics (53 citations), Organic Chemistry (96 citations) and Pharmacology (29 citations). Pritha Bose has collaborated with scholars based in India, United Kingdom and Israel. Frequent co-authors include Shakti Prasad Pattanayak, Antonio Lapenna, Priyashree Sunita, Mohd Usman Mohd Siddique, Rajiv K. Kar, Amiya Priyam, Puja Kumari, Sharad Srivastava, Venkatesan Jayaprakash and Barij Nayan Sinha. Their work appears in journals such as Pharmacognosy Magazine, Biomedicine & Pharmacotherapy, Current Microbiology, Scientific Reports and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.